The Nitric Oxide- and Prostaglandin-Independent Component of the Renal Vasodilator Effect of Thimerosal Is Mediated by Epoxyeicosatrienoic Acids
Open Access
- 25 November 2002
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 304 (3), 1292-1298
- https://doi.org/10.1124/jpet.102.042671
Abstract
Epoxyeicosatrienoic acids (EETs) are cytochrome P450-derived metabolites of arachidonic acid that elicit vasodilation via activation of K+ channels. They have been implicated as endothelium-derived hyperpolarizing factors (EDHFs), mediating the effect of some endothelium-dependent vasodilator agents such as bradykinin in some vascular tissues. We reasoned that an agent that increases the availability of free arachidonic acid should also elicit cytochrome P450-dependent vasodilation that is associated with increased release of EETs and attenuated by agents that inhibit the synthesis or action of EETs. Thus, we used thimerosal as an inhibitor of reacylation of arachidonic acid and determined the contribution of prostaglandins, nitric oxide, and EETs to the vasodilator effect in the isolated, perfused, preconstricted kidney of the rat. Thimerosal elicited vasodilator responses that were unaffected by inhibition of cyclooxygenase with indomethacin but were reduced by the further inhibition of nitric oxide synthesis. The vasodilator activity that remained after inhibition of cyclooxygenase and nitric oxide synthase was reduced by inhibition of K+ channels with tetraethylammonium and was associated with increased release of EETs measured by gas chromatography-mass spectroscopy following hydrolysis to the corresponding diols. Inhibition of cytochrome P450 with miconazole or epoxygenase withN-methylsulfonyl-6-(2-propargyloxyphenyl)hexamide reduced the nitric oxide- and prostaglandin-independent vasodilator effect of thimerosal and attenuated the increase in the release of EETs. We conclude that thimerosal causes vasodilation of the isolated perfused kidney via nitric oxide-dependent and -independent mechanisms. The nitric oxide-independent component of the response involves activation of K+ channels and is likely mediated by EETs, possibly acting as EDHFs.Keywords
This publication has 27 references indexed in Scilit:
- What is new in endothelium-derived hyperpolarizing factors?Current Opinion in Nephrology and Hypertension, 2002
- Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endotheliumAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- K+ is an endothelium-derived hyperpolarizing factor in rat arteriesNature, 1998
- Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Endothelium-Dependent HyperpolarizationCirculation, 1995
- Thimerosal blocks stimulated but not basal release of endothelium‐derived relaxing factor (EDRF) in dog isolated coronary arteryBritish Journal of Pharmacology, 1992
- Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N omega-nitro-L-arginine.Hypertension, 1991
- Thimerosal hyperpolarizes arterial smooth muscles in an endothelium-dependent mannerEuropean Journal of Pharmacology, 1990
- A novel pool of rat liver inositol and ethanolamine phospholipids contains epoxyeicosatrienoic acids (EETs)Biochemical and Biophysical Research Communications, 1987